- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04289116
Enhancing Sexual Safety: Couples' Communication and HIV Testing Among YMSM (WeTestATN156)
July 5, 2022 updated by: Sylvie Naar, Florida State University
The purpose of this study is to compare different ways to deliver the couples HIV Testing and Counseling (CHTC) intervention that is suited for adolescents and young adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Investigators will conduct a comparative effectiveness trial (CET) of CHTC for adolescent-age (15-24 years) same-sex male couples.
This design tests the added benefits of adjunct intervention components delivered prior to receipt of CHTC-Assertive Communication Training (ACT) videos viewed by the individual or couple together and individually delivered Motivational Interviewing-based Communication Skills Training (MI-CST).
These target the development of communication skills necessary to participate fully in HIV prevention and sexual safety discussions inherent to CHTC.
Youth will be randomized to receive one of two conditions: Condition 1: watch videos on ACT, participate in Communication Skills Training (MI-CST), and complete an individual HIV test, or if participating as a couple will receive CHTC, and Condition 2: Individual HIV Testing (IHTC) as usual.
Youth have the choice of attending the baseline visit alone or with their partner and have the option to bring their partner in later after completing the baseline alone.
Youth in this CET will complete follow-up assessments at 1, 3, and 6 months.
Study Type
Interventional
Enrollment (Actual)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92103
- San Diego LGBT Community Center
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Wayne State University
-
-
New York
-
New York, New York, United States, 10018
- The City University of New York
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 22 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- At least one partner must be HIV-negative or status unknown
- THE INDEX PARTNER must be 15-24 years old
- YMSM under age 18 MUST HAVE AN AGE CONCORDANT PARTNER TO PARTICIPATE IN THIS STUDY, I.E., MINORS may only participate in the study with a partner within 2 years of age OF THE MINOR SUBJECT'S AGE. THE AGE CONCORDANT PARTNER MUST BE AT LEAST FIFTEEN YEARS OLD.
- INDEX PARTNER MUST BE SEXUALLY ACTIVE (ANY ACTIVITY THAT COULD LEAD TO ORGASM)
- CURRENTLY SEEING SOMEONE, DATING, EXPERIMENTING WITH RELATIONSHIPS OR IN A RELATIONSHIP
- HAVE HAD SEX, HOOKED UP WITH OR MADE OUT WITH THAT PERSON
- Both partners must be able to communicate in English.
- LIVE IN OR NEAR NEW YORK CITY OR DETROIT OR SAN DIEGO
- GENDER IDENTITY AS MALE OR nonbinary, GENDERQUEER, agender OR GENDER NONCOMFORMING
Exclusion Criteria:
- Unstable, serious psychiatric symptoms
- Current suicidal/homicidal ideation
- Current or prior Intimate Partner Violence (IPV) on the part of either relationship partner
- IF EITHER PARTICIPATING PARTNER FELT PRESSURED OR COERCED TO PARTICIPATE IN THE STUDY OR FELT ANYONE MADE THEM FEEL THEY HAD TO PARTICIPATE IN THEY STUDY WHEN THEY DID NOT WANT TO.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: We Test
Each participant or couple will receive MI-CST + observation of ACT videos + CHTC.
Youth have the choice of attending the baseline visit alone or with their partner and have the option to bring their partner in later after completing the baseline alone.
|
This design tests the added benefits of adjunct intervention components delivered prior to receipt of CHTC-Assertive Communication Training (ACT) videos viewed by the couple separately and individually delivered Motivational Interviewing-based Communication Skills Training (MI-CST).
These target the development of communication skills necessary to participate fully in HIV prevention and sexual safety discussions inherent to CHTC.
|
Active Comparator: Individual HIV Testing and Counseling
Individual HIV Testing and Counseling (IHTC).
Youth have the choice of attending the baseline visit alone or with their partner and have the option to bring their partner in later after completing the baseline alone.
|
Individual HIV Testing and Counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HIV Transmission Risk Behavior
Time Frame: 30 days
|
Self-reported Condomless anal sex in the absence of PrEP
|
30 days
|
Bacterial STI infection in the absence of PrEP
Time Frame: 30 days
|
APTIMA (TMA RNA test) for Urine and Rectal samples
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Communication skills
Time Frame: 30 days
|
Interpersonal Communication Competence Scale, higher scores are associated with better communication skills, range 0 - 120
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Tyrel Starks, PhD, The City University of New York
- Study Chair: Sarah W Feldstein Ewing, PhD, University of Rhode Island
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2020
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
February 14, 2020
First Submitted That Met QC Criteria
February 27, 2020
First Posted (Actual)
February 28, 2020
Study Record Updates
Last Update Posted (Actual)
July 7, 2022
Last Update Submitted That Met QC Criteria
July 5, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MOD00000199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Currently, there is no plan to share the study data at this time; however, the study team is currently in the process of developing a plan to share data, while protecting the privacy and confidentiality of participants.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | HIV SeronegativityUnited States, Puerto Rico
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
Clinical Trials on We Test
-
Boston Medical CenterNational Institute on Minority Health and Health Disparities (NIMHD); Center...CompletedObesity | Asthma | Blood Pressure | Child Development | Health Care Utilization | Child Maltreatment | Health Care Disparities | Basic Unmet Social NeedsUnited States
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Massachusetts, WorcesterBoston University; Eunice Kennedy Shriver National Institute of Child Health... and other collaboratorsCompletedPatient Satisfaction | Basic Unmet Material Needs | Receipt of Community Resources | Provider ReferralsUnited States
-
Northeastern UniversityCompleted
-
University of Illinois at ChicagoRecruitingIntellectual DisabilityUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
University of ArkansasNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Aronora, Inc.Completed
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVUnited States